Table 1 Baseline demographic and clinical characteristics of patients
From: Association between markers of glycemia and carotid intima-media thickness: the MARK study
|  | Global (n = 427) | Diabetics (n = 92) | Non-Diabetics (n = 335) | p value |
|---|---|---|---|---|
Age (years) | 60.3 ± 8.5 | 59.7 ± 84.5 | 81.3 ± 113.4 | 0.483 |
Gender (women) n (%) | 236 (55.3) | 63 (68.5) | 173 (51.6) | 0.004 |
Smoker n (%) | 82 (21.5) | 19 (20.7) | 73 (21.8) | 0.887 |
Alcohol drinking (gr/week) | 76.6 ± 108.1 | 60.9 ± 8.8 | 60.2 ± 8.4 | 0.089 |
METs/hour/week | 3623 ± 3431 | 3378 ± 3153 | 3691 ± 3506 | 0.440 |
Body mass index (kg/m2) | 28.3 ± 4.2 | 29.8 ± 5.0 | 27.9 ± 3.9 | <0.001 |
Abdominal perimeter (cm) | 97.5 ± 10.6 | 102.4 ± 11.7 | 96.2 ± 9.9 | <0.001 |
Obesity patients n (%) | 128 (27.6) | 38 (41.3) | 80 (23.9) | 0.001 |
Office SBP (mmHg) | 134 ± 17 | 137.0 ± 14.7 | 133.4 ± 17.1 | 0.067 |
Office DBP (mmHg) | 81 ± 11 | 79.7 ± 10.1 | 81.5 ± 11.1 | 0.169 |
Office MBP (mmHg) | 93 ± 10 | 93.4 ± 9.2 | 93.1 ± 9.7 | 0.783 |
Office Heart rate (bpm) | 70 ± 11 | 73.0 ± 12.1 | 69.3 ± 10.8 | 0.005 |
Hypertensive patients n (%) | 340 (79.6) | 76 (82.6) | 264 (78.8) | 0.468 |
Antihypertensive Drugs n (%) | 230 (53.9) | 60 (65.2) | 170 (50.7) | 0.018 |
FPG (mg/dL) | 97.9 ± 31.1 | 137.5 ± 46.1 | 87.0 ± 10.1 | <0.001 |
Average PG (mg/dL) | 120.2 ± 32.4 | 152.4 ± 9.5 | 111.3 ± 17.6 | <0.001 |
HbA1c (%) | 5.9 ± 1.0 | 7.2 ± 1.4 | 5.6 ± 0.3 | <0.001 |
Diabetics patients n (%) | 92 (21.5) | 92 (21.5) | 0 (0.0) | --- |
Antidiabetic drugs n (%) | 76 (17.8) | 76 (82.6) | 0 (0.0) | --- |
Total Cholesterol (mg/dl) | 215.0 ± 38.93 | 193.1 ± 41.1 | 221.0 ± 36.1 | <0.001 |
LDL Cholesterol (mg/dl) | 134.3 ± 34.5 | 113.4 ± 35.5 | 140.1 ± 32.0 | <0.001 |
HDL-Cholesterol (mg/dl) | 55.1 ± 14.3 | 51.6 ± 13.0 | 56.1 ± 14.5 | 0.009 |
Tryglicerides (mg/dl) | 129.4 ± 92.6 | 149.0 ± 138.4 | 124.0 ± 74.8 | 0.022 |
No HDL-Cholesterol (mg/dl) | 80.2 ± 13.8 | 79.8 ± 16.3 | 80.2 ± 13.0 | 0.805 |
Dyslipidemia patients n (%) | 363 (85) | 66 (71.7) | 297 (88.7) | <0.001 |
Lipid lowering drugs n (%) | 158 (37) | 56 (60.9) | 102 (30.4) | <0.001 |
Average mean IMT (mm) | 0.738 ± 0.096 | 0.768 ± 0.111 | 0.729 ± 0.089 | 0.001 |
Carotid plaques n (%) | 75 (17.6) | 28 (30.4) | 47 (14.1) | <0.001 |
TOD carotid n (%) | 77 (18.0) | 29 (31.5) | 48 (14.3) | <0.001 |
Average maxima IMT (mm) | 0.906 ± 0.117 | 0.942 ± 0.136 | 0.896 ± 0.109 | 0.001 |